When surgical polypectomy and not segmental resection is planned, preoperative endoscopic tattooing with high-volume undiluted methylene blue should be avoided as it can result in colon perforation. K E Y W O R D S colonoscopy, tattooing, methylene blue, surgery, polypectomy, perforation F I G U R E 1 CT depicted extensive rectosigmoid wall thickening and pelvic extravasation of gas and fluid | 2259 BLOUHOS et aL.
A 76-year-old male patient referred to our surgical endoscopy department for polypectomy of a large pedunculated distal sigmoid villous adenoma. As the polyp considered endoscopically unresectable, tattooing with 2 mL fourquadrant submucosal injection of undiluted methylene blue (10-mL sterile vials, 0.5%-50 mg/10 mL) was performed. Immediate open polypectomy with minor colotomy was performed instead of segmental resection. On postoperative day 3, symptoms and signs of peritonitis developed. CT depicted rectosigmoid wall thickening and pelvic gas and fluid extravasation ( Figure 1 ). Relaparotomy revealed blue discoloration of the colotomy site along with patchy black serosal areas and suture line rupture treated with Hartmann's procedure ( Figure 2 ). Histology revealed transmural sigmoid wall necrosis at the colotomy site.
| QUIZ QUESTION: WHAT

WENT WRONG?
Methylene blue (MB) is a poor endoscopic tattoo agent occasionally used in clinical practice without standardization in respect of volume and dilution. Currently used agents include India ink (10-mL sterile vials, diluted 1:50 with normal saline) and Spot (5-mL sterile vials, ready to use). Methylene blue is less useful with regard to ease of use, safety, and efficacy. 1 Early reactions especially to high-volume, low-dilution MB include mucosal or transmural ischemic ulceration and necrosis resulting in colonic wall abscess, perforation, and peritonitis, as in our patient's case. 
